The first and only FDA-approved, single-dose, sustained-release, intracameral steroid for the treatment of cataract postoperative inflammation

The first and only FDA-approved, single-dose, sustained-release, intracameral steroid for the treatment of cataract postoperative inflammation1-3

Learn an easy, consistent, reproducible injection technique

Watch videos of surgeons using their preferred method of administering DEXYCU (dexamethasone intraocular suspension) 9% to provide effective inflammatory control.